A collaborative study headed by EWBG, EWA, Baden, and Heidelberg University uncovers novel neuroanatomical insights into Down Syndrome, motivating tailored-care methods.
MRI studies have found a link between cognitive ability and brain volume changes, suggesting the possibility of early intervention.
The cooperation intends to reshape care for Down syndrome and associated illnesses.
EWBG, specialising in stem cell treatments, collaborates closely with Heidelberg University.
Prof. Mike Chan emphasises the importance of bioregenerative medicine’s long-term growth.
EWA offers advanced training, BADEN prioritises research, and Heidelberg University serves as a center for stem cell research and immunology.
Comments are closed.